FREQUENTLY ASKED QUESTIONS
FOR PATIENTS – FREQUENTLY ASKED QUESTIONS (FAQS) FOR RAPID COVID-19 IgG/IgM TESTING
PROVIDED BY DELAWARE HEALTH AND SOCIAL SERVICES
1. What does the COVID-19 Rapid IgG/IgM Rapid Test look for?
The rapid test evaluates for the presence of antibodies in your blood. These results can help guide your health care provider about your infection status.
2. Is the test FDA-approved?
The FDA has permitted distribution of tests that have received or that have applied for an Emergency Use Authorization (EUA); however, the State of Delaware requires all tests that have not received an EUA undergo validation by an authorized laboratory.
3. Why does the test use blood instead of a nasal or oral swab?
The rapid test looks for the presence of antibodies, a component of the body’s natural immune response to infection. Nasal and oral swab tests use a different testing method to look for genetic material of the virus that causes COVID-19.
4. My health care provider said the test was negative, what does that mean?
This does NOT mean that you are not infected with COVID-19. Your health care provider may recommend additional testing. You must continue to isolate yourself at home, away from others, and should consider yourself to be infected until follow-up testing is completed and your health care provider indicates you can stop self-isolation.
5. I have symptoms, and my health care provider said the test was positive. What does that mean?
You are infected with COVID-19. Follow your health care provider’s directions. You must isolate from others until at least 3 days after your fever goes away and your breathing returns to normal and at least 7 days since you first noticed you were sick. Discuss with your employer or health department regarding when you may return to work.
6. Does the presence of antibodies mean I am immune to COVID-19?
At this time, little is known about the duration and strength of immune response to COVID-19. You should continue to follow all infection prevention instructions to avoid giving COVID-19 to others, including social distancing and wearing appropriate protective equipment including face coverings if in close contact with others.